Intensity Therapeutics removes James Ahlers as officer; stays as consultant

INTENSITY THERAPEUTICS, INC.

James Ahlers removed as officer effective May 21, 2024 per board resolution.
No longer designated as executive officer under Rule 16a-1(f) or Rule 3b-7.
Will continue in senior corporate finance consulting role via existing agreement with Danforth Advisors LLC.
Removal not due to any disagreement with company operations, policies, or practices.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

James Ahlers

Other Named Officer

INTS · INTENSITY THERAPEUTICS, INC.

Effective: 2024-05-21
Filed: May 24, 2024, 7:59 PM ET

On May 21, 2024, the Board of Directors of Intensity Therapeutics, Inc. (the “Company”) resolved that Mr. James Ahlers (i) shall be removed as an officer of the Company pursuant to the Company’s bylaws

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

James Ahlers was removed as other_named_officer at INTENSITY THERAPEUTICS, INC..

Action: removed

Exact text from the filing

On May 21, 2024, the Board of Directors of Intensity Therapeutics, Inc. (the “Company”) resolved that Mr. James Ahlers (i) shall be removed as an officer of the Company pursuant to the Company’s bylaws

View on SEC.gov

INTENSITY THERAPEUTICS, INC. filing history →

Source: SEC EDGAR

accession 0001567264-24-000021

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.